Biote Corp. Form 8-K Summary
Business Context and Reporting Period
Biote Corp. filed this Current Report on Form 8-K on August 24, 2022, reporting executive management changes. The company is incorporated in Delaware and its Class A common stock and warrants traded on the OTC Pink Open Market under symbols BTMD and BTMDW, respectively.
Key Financial Metrics and Capitalization
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics. The filing states that the CFO transition is unrelated to the company’s quarterly financial results, accounting principles, practices, or financial disclosures.
Material Changes Versus the Prior Comparable Period
- Samar Kamdar was appointed Chief Financial Officer, principal accounting officer, and principal financial officer, effective August 24, 2022.
- Robbin Gibbins transitioned out of the CFO role effective immediately and was expected to remain employed through November 15, 2022, assisting with the transition and special projects.
- The transition was described as mutually agreed and unrelated to quarterly financial results or disagreements over accounting or financial disclosure matters.
Compensation, Outlook, Risks, and Unusual Items
- Mr. Kamdar’s employment agreement provides for an annual base salary of $350,000, an annual bonus opportunity of up to 40% of base salary, and an initial grant of 250,000 stock options under the 2022 Equity Incentive Plan.
- The agreement is at-will and also provides eligibility for company benefit plans and programs.
- The company expected to enter into a transition agreement with Mr. Gibbins covering his continued employment through November 15, 2022. The filing states that the agreement’s description is based on current expectations and is not complete.
- The full Kamdar employment agreement and any Gibbins transition agreement were expected to be filed as exhibits to the company’s Form 10-Q for the quarter ending September 30, 2022.
- The filing does not provide financial guidance or an operating outlook.
Important Facts to Verify
- Whether the anticipated transition agreement with Mr. Gibbins was executed and its final terms.
- The vesting schedule, exercise terms, and accounting expense associated with Mr. Kamdar’s 250,000 stock options.
- Subsequent financial results and any disclosures regarding the CFO transition in the September 30, 2022 Form 10-Q.
- Whether the management change affected financial reporting, internal controls, liquidity, or future guidance.